Published in Am J Pathol on August 11, 2011
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol (2012) 2.24
Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway. Arthritis Res Ther (2012) 0.88
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships. Microbiol Mol Biol Rev (2016) 0.81
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol (2003) 10.21
Interleukin-1 and interleukin-1 antagonism. Blood (1991) 7.67
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med (1999) 7.62
Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 6.44
Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science (2002) 5.82
Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem (1988) 5.75
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Defective T cell differentiation in the absence of Jnk1. Science (1998) 4.40
Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol (2001) 4.39
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med (1998) 3.70
Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity (1998) 3.70
Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol (1988) 2.80
The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol (1994) 2.69
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60
Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol (2000) 2.33
JNK2 is a positive regulator of the cJun transcription factor. Mol Cell (2006) 2.32
Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med (2003) 1.99
The K/BxN arthritis model. Curr Protoc Immunol (2008) 1.74
The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol (2000) 1.66
A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur J Immunol (2005) 1.65
Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol (1998) 1.55
The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol (2004) 1.38
Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum (2002) 1.36
Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res (2000) 1.35
Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther (2007) 1.29
The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med (2004) 1.27
JNK1 is required for T cell-mediated immunity against Leishmania major infection. J Immunol (2000) 1.15
Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol (1995) 1.05
In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol (2002) 1.05
PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. J Leukoc Biol (2007) 1.04
The JNK are important for development and survival of macrophages. J Immunol (2006) 1.00
JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis. Proc Natl Acad Sci U S A (2010) 0.99
JNK1 is not essential for TNF-mediated joint disease. Arthritis Res Ther (2004) 0.99
Collagen-induced arthritis in mice. Methods Mol Med (2007) 0.98
Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J Immunol (2005) 0.97
Animal models of rheumatoid arthritis and related inflammation. Curr Rheumatol Rep (1999) 0.95
JNK-1 deficiency limits macrophage-mediated antigen-induced arthritis. Arthritis Rheum (2011) 0.94
Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene (1996) 0.94
MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver. Blood (2005) 0.92
Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J Leukoc Biol (2001) 0.91
Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain. Proc Natl Acad Sci U S A (2006) 0.86
Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen. Cell Immunol (1996) 0.85
Bone histomorphometry in arthritis models. Methods Mol Med (2007) 0.81
Correlation between IgG anti-type II collagen levels and arthritic severity in murine arthritis. Autoimmunity (1998) 0.80
Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis. Gene Ther (2001) 0.78
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation (2006) 7.01
Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science (2004) 3.66
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood (2011) 2.96
Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens (2009) 2.71
Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol (2010) 2.55
Knockout of Arabidopsis accelerated-cell-death11 encoding a sphingosine transfer protein causes activation of programmed cell death and defense. Genes Dev (2002) 2.51
Crystal structure of a soluble CD28-Fab complex. Nat Immunol (2005) 2.46
Ambulatory blood pressure and mortality: a population-based study. Hypertension (2005) 2.34
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens (2006) 2.03
IKK beta is required for peripheral B cell survival and proliferation. J Immunol (2003) 1.92
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol (2002) 1.89
A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol (2004) 1.86
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab Invest (2005) 1.86
Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol (2011) 1.86
Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer (2011) 1.84
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol (2007) 1.73
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res (2005) 1.73
Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. J Invest Dermatol (2011) 1.70
A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur J Immunol (2005) 1.65
Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens (2007) 1.48
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer (2003) 1.48
Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc Natl Acad Sci U S A (2003) 1.48
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. J Hypertens (2012) 1.47
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood (2006) 1.46
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens (2008) 1.45
Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens (2009) 1.40
Colocalization of L-phenylalanine ammonia-lyase and cinnamate 4-hydroxylase for metabolic channeling in phenylpropanoid biosynthesis. Plant Cell (2004) 1.40
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension (2005) 1.31
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J (2007) 1.30
CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J Immunol (2006) 1.30
Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens (2006) 1.28
The role of CC chemokine receptor 5 in antiviral immunity. Blood (2002) 1.28
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells. Cancer Res (2008) 1.23
High numbers of IL-2-producing CD8+ T cells during viral infection: correlation with stable memory development. J Gen Virol (2002) 1.15
Metabolomics or metabolite profiles? Trends Biotechnol (2005) 1.15
Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J Neurosci (2004) 1.13
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer Biol Ther (2011) 1.10
Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors. Cancer Immunol Immunother (2007) 1.09
MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines. J Immunol (2008) 1.09
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood (2013) 1.09
Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines. Immunol Lett (2003) 1.07
Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice. J Immunol (2005) 1.06
C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil (2008) 1.05
Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes. J Immunol (2008) 1.05
High-throughput direct-infusion ion trap mass spectrometry: a new method for metabolomics. Rapid Commun Mass Spectrom (2007) 1.05
Expression of the R2R3-MYB transcription factor TaMYB14 from Trifolium arvense activates proanthocyanidin biosynthesis in the legumes Trifolium repens and Medicago sativa. Plant Physiol (2012) 1.05
miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One (2012) 1.02
Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination. J Immunol (2010) 1.01
Few human autoimmune sera detect GPI. Nat Immunol (2002) 1.00
A novel xenograft model of cutaneous T-cell lymphoma. Exp Dermatol (2010) 0.99
The importance of lytic and nonlytic immune responses in viral infections. Trends Immunol (2002) 0.99
Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma. Hum Pathol (2007) 0.99
Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. J Immunol (2007) 0.98
Protein kinase C (PKC) alpha and PKC theta are the major PKC isotypes involved in TCR down-regulation. J Immunol (2006) 0.97
Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur J Immunol (2002) 0.97
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum (2007) 0.97
Raft association and lipid droplet targeting of flotillins are independent of caveolin. Biol Chem (2007) 0.97
IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. Blood (2007) 0.97
Flotillins are involved in the polarization of primitive and mature hematopoietic cells. PLoS One (2009) 0.97
A reverse-phase liquid chromatography/mass spectrometry method for the analysis of high-molecular-weight fructooligosaccharides. Anal Biochem (2009) 0.97
The lipid raft microdomain-associated protein reggie-1/flotillin-2 is expressed in human B cells and localized at the plasma membrane and centrosome in PBMCs. Immunobiology (2002) 0.96
Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. J Immunol (2011) 0.95
Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis. APMIS (2010) 0.95
IL-23-mediated epidermal hyperplasia is dependent on IL-6. J Invest Dermatol (2011) 0.95
The role of the complement and the Fc gamma R system in the pathogenesis of arthritis. Arthritis Res Ther (2005) 0.95
Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens (2006) 0.95
Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process. Microvasc Res (2009) 0.95
Advanced data-mining strategies for the analysis of direct-infusion ion trap mass spectrometry data from the association of perennial ryegrass with its endophytic fungus, Neotyphodium lolii. Plant Physiol (2008) 0.94
A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol Immunol (2005) 0.94
Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract (2005) 0.93
Cloning, expression, and alternative splicing of neogenin1 in zebrafish. Mech Dev (2002) 0.92
MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver. Blood (2005) 0.92
EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. Int J Cancer (2008) 0.92
Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation. J Virol (2013) 0.91
Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel) (2013) 0.91
Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice. J Immunol (2011) 0.91
Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells. PLoS One (2011) 0.90
Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles. J Immunol (2005) 0.90
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood (2011) 0.90
Cytokine production by virus-specific CD8(+) T cells varies with activation state and localization, but not with TCR avidity. J Gen Virol (2004) 0.90
Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection. J Immunol (2004) 0.89
Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production. J Virol (2006) 0.89
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins. Blood (2006) 0.89
Measures of overweight and obesity and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil (2010) 0.89
A theoretical framework for quantitative analysis of the molecular basis of costimulation. J Immunol (2005) 0.89
Semi-quantitative and structural metabolic phenotyping by direct infusion ion trap mass spectrometry and its application in genetical metabolomics. Rapid Commun Mass Spectrom (2009) 0.89
Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes. Int Immunol (2005) 0.89
D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells. J Neuroimmunol (2005) 0.89
Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study. Atherosclerosis (2006) 0.89
A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF. Mol Immunol (2006) 0.89
B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur J Immunol (2003) 0.89
Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma (2013) 0.89
Metabolite analysis of the effects of elevated CO2 and nitrogen fertilization on the association between tall fescue (Schedonorus arundinaceus) and its fungal symbiont Neotyphodium coenophialum. Plant Cell Environ (2013) 0.89
E/Z-Thesinine-O-4'-alpha-rhamnoside, pyrrolizidine conjugates produced by grasses (Poaceae). Phytochemistry (2008) 0.88